African Stock ExchangesΞ

IIL - Intravenous Infusions Limited

Twitter · Facebook
IIL on Ghana Stock Exchange. Stock analysis for Intravenous Infusions Limited including share price chart, dividend and company profile.Stock summary for IIL on the Ghana Stock Exchange

Intravenous Infusions Limited (IIL) is a Ghanaian pharmaceutical company and the market leader in the manufacture of intravenous infusions in the country. IIL was incorporated in 1969 and began operations in 1974 as the first pharmaceutical company producing intravenous infusions in Ghana. The company was set up to take advantage of the total lack of local production of infusions and the country's dependence on imports. Since then, IIL has grown to become the dominating market leader with a market share of about 50% in the country. The company also exports its products to the immediate neighboring countries, namely, Ivory Coast, Burkina Faso, and Togo. Intravenous Infusions Limited listed on the Ghana Alternative Market in December 2015.

IIL0.09 ▪ 0.00 (0%) 11 hours ago
Last Trading ResultsGrowth & Valuation
Opening Price:--Earnings Per Share:0.00
Day's Low Price:0.09Price/Earning Ratio:--
Day's High Price:0.09Dividend Per Share:--
Traded Volume:72,400Dividend Yield:--
Number of Deals:2Shares Outstanding:226.64m
Value/Turnover:6,516.00Market Capitalization:20.4m

Monetary values are quoted in Ghana Cedis (GHS) unless otherwise stated

IIL Market Performance

IIL currently ranks 12th on the Ghana Stock Exchange in terms of returns to investors with a year-to-date return of zero percent. Following IIL are EGL (-0.42%), TBL (-3.85%), and ACCESS (-4.88%). Shareholders are anxiously awaiting when Intravenous Infusions Limited will announce dividends to see whether they have gained something or not. Below is the historical trading trend of IIL, covering up to the last 10 trading sessions of activity.

DateVolumeOpenCloseChange%Change
2017-04-2572,4000.090.09+0.000.00%
2017-04-135,1000.090.09+0.000.00%
2017-04-0418,2000.090.09+0.000.00%
2017-03-291,3000.090.09+0.000.00%
2017-02-161,5000.090.09+0.000.00%
2017-02-151000.090.09+0.000.00%
2017-02-1010,0000.090.09+0.000.00%
2017-02-091,6000.090.09+0.000.00%
2017-01-2313,3000.090.09+0.000.00%
2017-01-123,0000.090.09+0.000.00%

Profile of Intravenous Infusions Limited

Intravenous Infusions Limited operates in the Health Care sector, specifically, the Pharmaceuticals & Biotechnology industry—according to the reverse Industry Classification Benchmark (ICB) taxonomy. The company's board of directors is composed of eight members whose names are listed below.

  1. Isaac Osei
    Chairman
  2. Richard Okrah
    Managing Director
  3. Michael Amafu-Dei
    Director
  4. Kofi Appenteng
    Director
  5. Samuel A. Appenteng
    Director
  6. Leon Appenteng
    Director
  7. Nana Owusu Banahene
    Director
  8. Gladys Amposah
    Director (Alternate)
Factsheet of Intravenous Infusions Limited
Sector:
Health Care
Industry:
Pharmaceuticals & Biotechnology
Address:
Plot 4/7 BIKL, Adjacent Highways workshop, Akwadum Road, Effiduase-Koforidua
Telephone:
+233-342-020-151
Facsimile:
+233-342-020-125
Email:
info@iil.com.gh
Website:
www.iil.com.gh

Industrial Stock Market Competitors

Intravenous Infusions Limited, issuers of the IIL stock on the Ghana Stock Exchange, have two market competitors who are also engaged in the Health Care/Pharmaceuticals & Biotechnology industry. The table below gives you an overview of their market standing.

SymbolCompanyMkt. Cap.PriceChange
AYRTNAyrton Drugs Manufacturing Co. Ltd.21.50m0.10+0.00
SPLStarwin Products Limited5.20m0.02+0.00

Index of African Stock Exchanges:

  1. Botswana Stock Exchange
  2. Ghana Stock Exchange
  3. Malawi Stock Exchange
  4. Nairobi Securities Exchange
  5. Nigerian Stock Exchange
  6. Zimbabwe Stock Exchange

Post a comment

    NOTE: You are replying to 's comment. [Cancel]